An overview of pharmacotherapy-induced ototoxicity

References

• Handelsman JA. Vestibulary ototoxicity: the importance and pragmatics of monitoring. Seminars in Hearing/Volume. 2011;32 (3):262–272.
   Google Scholar
• Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13(1):119–126.
   PubMed Web of Science ®Google Scholar
• Stach BA. Clinical audiology: an introduction. Delmar: Singular Publishing Group; 1998.
   Google Scholar
• Hall JW. Handbook of otoacoustic emissions. Stamford: Thomson Learning; 2000.
   Google Scholar
• Hall JW. New handbook of auditory evoked responses. Boston: Pearson Education; 2007.
   Google Scholar
• Rutka J. Physiology of the vestibular system. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Steyger PS. Mechanisms involved in ototoxicity. Seminars in Hearing/Volume. 2011;32 (3):217–228.
   PubMedGoogle Scholar
• Mathers DM, Fat DM, Boerma JT, World Health Organization. The global burden of disease. World Health Organization. Geneva: WHO; 2008.
   Google Scholar
• Vergnano S, Sharland M, Kazembe P, et al. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F220–F224.
   PubMed Web of Science ®Google Scholar
• Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol. 2011;2011:937861.
   PubMedGoogle Scholar
• Steyger PS, Hongzhe L. Systemic aminoglycosides are trafficked via endolymph into cochlear hair cells. Sci Rep. 2011;1:159.
   PubMed Web of Science ®Google Scholar
• Knight KR, Kraemer DF, Winter C, Neuwelt EA. Early changes in auditory function as a result of platinum chemotherapy: use of extended high frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007;10 (25):1190–1195.
   Web of Science ®Google Scholar
• Sturgeon J. Clinical uses of cisplatin. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Gratton MA, Smyth BJ. Ototoxicity of platinum compounds. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Scott AR, Rutka JA. Macrolides. Ototoxicity. In: Rutka PS, Rutka JA, editors). Ontario: Hamilton; 2004.
   Google Scholar
• Umstead GS, Neumann KH. Erythromycin ototoxicity and acute psychotic reaction in cancer patient with hepatic dysfunction. Arch Inter Med. 1986;146(5):879–899.
   Google Scholar
• Bizak ED, Houg MT, Schilz RJ, et al. Intravenous azithromycin-induced ototoxicity. Pharmacotherapy. 1999;19(2):245–248
   PubMed Web of Science ®Google Scholar
• Rossiter D, editor. South African medicines formulary. 9th ed. Cape Town: Health and Medical Publishing Group; 2010.
   Google Scholar
• Baldwin KA, Budzinski CE, Shapiro CJ. Acute sensorineural hearing loss: furosemide ototoxicity revisited. Hospital Pharmacy. 2008;43(12):982–987.
   Google Scholar
• Prepageran N, Scott AR, Rutka JA. Ototoxicity of loop diuretics. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Hoshino T, Tabuchi K, Hara A. Effects of NSAIDs on the inner ear: possible involvement in cochlear protection. Pharmaceuticals. 2010;3:1286–1295.
   Google Scholar
• Prepageran N, Rutka JA. Salicylates, nonsteroidal anfi-inflammatory drugs, quinine and heavy metals. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Campbell KCM. Pharmacology and ototoxicity for audiologists. Albany: Thompson Delmar Learning; 2006.
   Google Scholar
• Konrad-Martin D, Helt WJ, Reavis KM, et al. Ototoxicity: early detection and monitoring. ASHA Leader. 2005;1:11–14.
   Web of Science ®Google Scholar
• American Academy of Audiology. Position statement and clinical practice guidelines: ototoxicity monitoring [homepage on the Internet]. 2009. Available from: www.audiology.org/resources/documentlibrary/Documents/OtoMonPositionGuideline.pdf
   Google Scholar
• Lonsbury-Martin BL, Martin GK. Evoked otoacoustic emissions as objective screeners for ototoxicity. Seminars in Hearing. 2001;22:377–391.
   Google Scholar
• Norton SJ. Cochlear function and otoacoustic emissions. Seminars in Hearing. 1992;13:1–14.
   Google Scholar
• Beattie RC, Kenworthy OT, Luna CA. Immediate and short-term reliability of distortion-product otoacoustic emissions. In J Audiol. 2003;42(6):348–354.
   PubMed Web of Science ®Google Scholar
• Knight KR, Kraemer DF, Winter C, Neuwelt A. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007;25(10):1190–1195.
   PubMed Web of Science ®Google Scholar
• Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Ann N Y Acad Sci. 1999;884:99–109.
   PubMed Web of Science ®Google Scholar
• Kisilevsky VE, Tomlinson RD, Ranalli P Prepageran N. Monitoring vestibular ototoxicity. Ototoxicity. In: Rutka PS, Rutka JA, editors. Ontario: Hamilton; 2004.
   Google Scholar
• Jacobson GP, Newman CW, Kartush JM. Handbook of balance function testing. St Louis: Mosby Year Book; 2003.
   Google Scholar